Portfolio map · VC firm · Australia
Brandon Capital portfolio map
22 startups Brandon Capital has backed in rounds we track, since 2018, grouped by their main sector. Together they have raised $1.3B; Brandon Capital led at least one round in 1 of them. The biggest sector is Biotech, with 15 companies.
Biotech
15
Funding by segment
- Biotech$1.1B15
- Pharma$150M4
- Healthtech$57M3
Where they are based
- Australia11$707M
- United Kingdom6$473M
- United States3$121M
- New Zealand2$20M
Australia
United Kingdom
United States
New ZealandFounded
3 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M5
- $10M to $50M8
- $50M to $250M7
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
19 of 22 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- Australia11
- United Kingdom6
- United States3
- New Zealand2
Startups by country, 4 countries in all.
Segment by segment
Biotech
15 startups · $1.1B raised
AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M
AstronauTxAstronauTx Ltd.United Kingdom$124M
Pheon TherapeuticsPheon Therapeutics is a biotechnology company focused on developing next-generation Antibody-Drug Conjugates (ADCs) aimed at treatUnited Kingdom$120M
Myricx BioMyricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.United Kingdom$115M
VaxxasVaxxas Pty Ltd is a clinical-stage biotechnology company based in Brisbane, Queensland, Australia.Australia$89M
Allay TherapeuticsAllay Therapeutics is a clinical-stage biotechnology company based in San Jose, California, with operations in Singapore.United States$58M
PolyActivaPolyActiva is a Melbourne-based biotechnology company founded in 2010, specializing in innovative drug delivery technology for ophAustralia$35M
Pathios TherapeuticsPathios Therapeutics is a clinical-stage biotechnology company based in Oxford, UK, founded in 2017.United Kingdom$34M
Pharma
4 startups · $150M raised
NRG TherapeuticsNRG Therapeutics Ltd is a private biotechnology company focused on drug discovery for neurodegenerative disorders.United Kingdom$79M
Entact BioEntact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.United States$50M
OccuRxOccuRx is an Australian biopharmaceutical company based in Melbourne, founded in 2014.Australia$20M
Respirion PharmaceuticalsRespirion Pharmaceuticals is an early-stage biotechnology company focused on developing new treatments for respiratory diseases.Australia$649K
Healthtech
3 startups · $57M raised
LumonusHello.Australia$46M- DDentericAustralia$9.4M
George MedicinesGeorge Medicines is a late-stage biopharmaceutical company dedicated to developing innovative single-pill combination therapies foUnited Kingdom$1.0M
How this map is made. Every startup here has raised money in a round we track that names Brandon Capital as an investor, the first in 2018. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Brandon Capital?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.